TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Rate of hypoxaemia, hypotension, or hypertension events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Effectiveness of Indian Hepatoprotective Diet in hepatic steatosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in CYBOCS-PDD repetitive behaviors measure score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ABC irritability self-injurious behaviors items score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of prescription of SGLT-2i medication
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Nature and quantity of bacteria identified
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Pain levels measured by VAS-P
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Compliance
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Incidence of Transient Chimerism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of Chimerism Transition Syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of tolerance induction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean % Reduction of Bowel Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Attention Deficit Hyperactivity Disorder symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social responsiveness
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Rate of perioperative ipsilateral ischemic stroke (%)
Endpoint domain: Mortality/survival
Primary endpoint: Rate of any stroke (%)
Endpoint domain: Mortality/survival
Primary endpoint: Rate of Myocardial infarction (%)
Endpoint domain: Mortality/survival
Primary endpoint: Rate of Hemorrhagic complications (%)
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of Surgical site infection (%)
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of Death (%)
Endpoint domain: Mortality/survival
Primary endpoint: Rate of main adverse cardiovascular events (%)
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnostic efficacy of 68Ga-C1 PET/CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: EORTC CTC AE Score
Endpoint domain: Adverse events/effects
Primary endpoint: Dysphagia score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Detection of Nerve Alterations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Acceptability of formulation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SARS-CoV-2 Specific Immunoglobulin (Ig)G Antibodies at 28-days Post Booster Vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total Incidence of Solicited Reactions (Systemic and Local)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of MRI abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in North Star Assessment for Limb Girdle Muscular Dystrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients undergoing nipple sparing mastectomy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: arthrokinematics of cervical spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate of CD4bs-specific IgG binding antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Magnitude of CD4bs-specific IgG binding antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum level of sCD25
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: voiding score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: erectile function score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of gabapentinoids
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Prevalence of opioids
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Changes in swallowing function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in spontaneous swallowing frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Finnish Diabetes Risk Score (FINDRISC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Healthy eating index-2015 (HEI-2015)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Neonatal birthweight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Best Overall Objective Response Rate (bORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic yield of colonoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Post-concussion symptom inventory (PCSI) total score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to return to full activity post injury
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Hospitalization for RSV-related respiratory tract disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Sheehan disability scale (SDS)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Quality of Life, short form 6 (QOL-6)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Psychosocial Function Questionnaire in Patients with Depression (PFQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Correlation of cervical examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preliminary efficacy signals from PET images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in skin microbiome composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change from baseline in AD severity scoring based on Eczema Area and Severity Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change from baseline in itching via Visual Analogue Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in self-reliance
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in Help-seeking behaviour
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Hopelessness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time of parental presence
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in visual field mean deviation (MD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Validation and reproducibility testing for blood assays
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Validation and reproducibility testing for glucose tolerance testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Validation and reproducibility testing for DEXA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healthy Lifestyle Behavior Scale II (HLBS II)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: International Physical Activity Questionnaire-Short Form (IPAQ-SF)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Positive and Negative Affect Schedule (PANAS-SF)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: hemorrhage rate after coblation tonsillectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects meeting primary efficacy endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global Symptomatic Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 9-item Patient Health Questionnaire (PHQ-9) total score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 10-item Perceived Stress Scale (PSS-10) total score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: A2AR expression in PBMCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: A2AR function in PBMC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Quadriceps Femoris Vastus Lateralis Muscle Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: VAS decrease of more than 50% at 30 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of severe adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of prediabetes or diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Lung atelectasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Metabolic complete response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Dice index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of knee joint stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of knee range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of walking quality (6-meters Walking Test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of walking quality (WOMAC score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment continuance
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean change in Trauma Symptom Checklist for Young Children (TSCYC)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean change in Short Mood and Feelings Questionnaire (SMFQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean change in Patient Reported Outcomes Measurement Information System Pediatric Item Bank v2.0 - Anxiety - Short Form 8a (PROMIS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in frailty index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of TENS Usage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Berg balance scale for functional balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait Abnormality Rating Scale (GARS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects who achieved ASAS40
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Box and Block test (BTT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in satisfaction with Care Coordination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Parent stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Family Satisfaction with Program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number and proportion of participants with adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects with significant abnormal laboratory values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects with significant abnormal Electrocardiography (ECG) findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of subjects With Significant Abnormal vital sign findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in dietary patterns and intake of fruit and vegetable
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in dietary carbon dioxide equivalents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in concentration of urinary pesticide residues in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of vessels with a positive response to Ach
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Background concentration of SARS-Co-V2 around COVID patients receiving NIV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Background concentration of SARS-Co-V2 when the iZephyr hood is in use
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Impact of iZephyr hood on environmental SARS Co-V2 contamination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cure rate after complete treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertical distance between medial and lateral malleolus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart Rate Error
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in NITM values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of smoking cessation interventions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood pressure (systolic and diastolic, mmHg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of smear positive, Xpert PCR positive, or CXR positive patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mean reaction time to the psychomotor vigilance task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper limb strength change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perinatal grief level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: General Well-Being Scale Short Form
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Self-report of sensory block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-report of motor block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in brain fog scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change From Baseline in Skin Oil Control Assessment During 12-hour Kinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change From Baseline in Clinical Effectiveness on Oil Shine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Sino nasal Outcome Test 22 (SNOT-22)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Computerized Tomography Scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UTI recurrent incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Change in normal pace-dual task cost (npDTC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative Effects Questionnaire (NEQ)
Endpoint domain: Adverse events/effects
Primary endpoint: Credibility and Expectancy Scale (CEQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change of pressure pain threshold using algometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of adverse events (AEs) characterized by severity
Endpoint domain: Adverse events/effects
Primary endpoint: Number of serious adverse events (SAEs) characterized by severity
Endpoint domain: Adverse events/effects
Primary endpoint: Propofol estimated concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Burst suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Foot function Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Item Short-Form Health Survey
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: VAS (Visual analogue scale)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Child's perceived pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Child's behavioral pain assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in child's state anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in RNs' pain documentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in RNs' pain knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Serum level of insulin like growth factor 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Neonatal hypotonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Electromyography of the masseter muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Muscle Inhibition level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Co-contraction index (CCI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Metabolizable Energy of the Diet
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in buprenorphine prescribing
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Fugl-Meyer Upper Extremity - hand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrence of apnea of prematurity (RAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of oxygen supplement after randomization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of hospital stay after randomization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Nasal cytokine responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rate of the bone marrow complete response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Gross Motor Scaled Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with adverse events (observed and self-reported)
Endpoint domain: Adverse events/effects
Primary endpoint: Overall diabetes distress score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Short Physical Performance Battery Protocol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in angina severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cognitive control (Stroop Task)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Impulsivity (Stop Signal Task)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cognitive control (Delay Discounting Task)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in Montgomery-Asberg Depression Rating Scale (MADRS) Total Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Retinal perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retinal vascular response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of the Combined tVNS + Mindfulness Intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Favorable Stroke Outcome at 90 days
Endpoint domain: Mortality/survival
Primary endpoint: Time spent in target glucose range (3.9-10.0 mmol/L)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence and type of dose-limiting toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: incidence and severity of treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Willingness to buy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients with symptomatic remission
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in memory gaps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time to inaccessible memory surfacing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of respiratory serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Difference in overall survival 'OS' between the two groups
Endpoint domain: Mortality/survival
Primary endpoint: Difference in progression free survival 'PFS' between the two groups
Endpoint domain: Mortality/survival